Lithium-induced inositol depletion in rat brain after chronic treatment is restricted to the hypothalamus

Molecular Psychiatry

Volumn 2, Issue 5, 1997, Pages 407-412

  Lubrich, B ^a   Patishi, Y ^b   Kofman, O ^b   Agam, G ^b   Berger, M ^a   Belmaker, R H ^b   Van Calker, D ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Affective disorder; Brain; CRH; Depression; Hypothalamus; Inositol; Lithium; Mania; Second messenger; Stress

Indexed keywords

INOSITOL; LITHIUM;

ANIMAL; ARTICLE; BRAIN; DRUG EFFECT; HYPOTHALAMUS; MALE; METABOLISM; RAT; SPRAGUE DAWLEY RAT; TIME;

ANIMALS; BRAIN; HYPOTHALAMUS; INOSITOL; LITHIUM; MALE; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 0031225466     PISSN: 13594184     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.mp.4000267     Document Type: Article

References (9)

1. American Psychiatric Association. Practice Guideline for the treatment of patients with bipolar disorder. Am J Psychiatry (Suppl) 1994; 151: 1-36.
2. Manji HK, Potter WZ, Lenox RA. Signal transduction pathways. Molecular target for lithium's action. Arch Gen Psychiatry 1995; 52: 531-543.
3. Berridge MJ, Downes CP, Hanley MR. Neural and development actions of lithium: a unifying hypothesis. Cell 1989; 59: 411-419.
4. Berridge MJ. Inositol triphosphate and calcium signalling. Nature 1993; 361: 315-325.
5. Jope RS, Williams MB. Lithium and brain signal transduction systems. Biochem Pharmacol 1994; 47: 429-441.
6. + in the treatment of bipolar disorder. Trends Neurosci 1995; 18: 343-349.
7. Nahorski SR, Ragan CI, Challiss RA. Lithium and the phosphoinositide cycle: an example of uncompetitive inhibition and its pharmacological consequences. Trends Pharmacol Sci 1991; 12: 297-303.
8. Patishi Y, Lubrich B, Berger M, van Calker D, Belmaker RH. Differential uptake of myo-inositol in vivo into rat brain areas. Eur Neuropsychopharmacology 1996; 6: 73-75.
9. Sherman WR, Leavitt AL, Honchar MP, Hallcher LM, Philips BE. Evidence that lithium alters phosphoinositide metabolism: chronic administration elevates primarily D-myo-inositol-1-phosphate in cerebral cortex of the rat. J Neurochem 1981; 36: 1947-1951.